Screener
GNOM vs EGLE
Global X Genomics & Biotechnology ETF vs Global X S&P 500 U.S. Revenue Leaders ETF
Key differences
- EGLE costs 0.31% less per year.
- GNOM is significantly larger than EGLE — larger funds tend to be more liquid and less likely to close.
- GNOM has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| GNOM | EGLE | |
|---|---|---|
| Annual cost (TER) | 0.50% | 0.19% |
| Fund size (AUM) | $51M | $2M |
| Since | 2019 | 2025 |
| Dividend yield | 1.38% | 0.98% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +53.6% | +14.8% |
| CAGR 3Y | -2.6% | N/A |
| CAGR 5Y | -10.5% | N/A |
| Sharpe 3Y | -0.06 | N/A |
| Volatility 1Y | 26.15% | 10.60% |
| Max drawdown | -75.00% | -9.78% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to GNOM and EGLE
Explore further